We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00398177
Recruitment Status : Recruiting
First Posted : November 10, 2006
Last Update Posted : November 17, 2016
Sponsor:
Collaborators:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Condition or disease
Lymphoma, Non-Hodgkin Hodgkin's Disease

Detailed Description:
This research involves the study of lymphoma cells in order to better understand how the disease grows and spreads. This study may lead to the development of special materials that could be used, in the future, to treat lymphoma or to follow the response of lymphoma to treatment.

Study Design

Study Type : Observational
Estimated Enrollment : 9999 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Study Start Date : January 1999
Estimated Primary Completion Date : January 2099

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. Collection of tumor tissue to characterize the molecular and cell biology of tumor cells in lymphoma. [ Time Frame: The study will continue indefinitely. ]

Biospecimen Retention:   Samples Without DNA
tumor tissue

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Any type of NHL or Hodgkin's disease.
Criteria

Inclusion Criteria:

  • Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.
  • Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).
  • A routine procedure for tissue collection is planned.
  • Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria:

  • Patients without NHL or Hodgkin's disease
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00398177


Contacts
Contact: Cancer Clinical Trials Office 650-498-7061 ccto-office@stanford.edu

Locations
United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Cancer Clinical Trials Office    650-498-7061    ccto-office@stanford.edu   
Principal Investigator: Ronald Levy         
Sub-Investigator: Gideon Gross         
Sub-Investigator: Shoshana Levy         
Sponsors and Collaborators
Stanford University
The Leukemia and Lymphoma Society
Biospect Inc
Investigators
Principal Investigator: Ronald Levy, MD Stanford University
More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT00398177     History of Changes
Other Study ID Numbers: LYM0001
76973 ( Other Identifier: Stanford University Alternate IRB Approval Number )
LYM0001 ( Other Identifier: OnCore )
IRB-13500 ( Other Identifier: Stanford IRB )
First Posted: November 10, 2006    Key Record Dates
Last Update Posted: November 17, 2016
Last Verified: November 2016

Additional relevant MeSH terms:
Lymphoma
Lymphoma, Non-Hodgkin
Hodgkin Disease
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases